Is Takeda Pharmaceutical Company Limited (TAK) a Buy, Sell, or Hold?
NYSE : TAK
Takeda Pharmaceutical Company Limited — Earnings Estimates
$17.24 USD
$0.42 (2.5%)
- Volume
- 3.27M
- Average Volume
- 3.22M
- Market Capitalization
- $54.85B
- P/E Ratio
- 46.31
- Dividend Yield
- 3.54%
- Price Target
- Year High
- $18.90
- Year Low
- $12.99
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.63
- Current Ratio
- $1.27
Annual earnings financials
TAK financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
TAK Estimated and Actual Revenue by Quarter
TAK Estimated and Actual EPS by Quarter
TAK Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-03-31 | 2 | 314.42B | 340.98B | 329.59B | 143.24B | 155.34B | 150.15B |
| 2027-12-31 | 3 | 329.62B | 357.46B | 345.52B | 150.17B | 162.85B | 157.41B |
| 2027-09-30 | 2 | 329.9B | 357.77B | 345.82B | 150.3B | 162.99B | 157.55B |
| 2027-06-30 | 2 | 322.63B | 349.88B | 338.19B | 146.99B | 159.4B | 154.08B |
| 2027-03-31 | 3 | 321.8B | 348.98B | 337.32B | 146.61B | 158.99B | 153.68B |
| 2026-12-31 | 3 | 338.49B | 367.09B | 354.82B | 154.21B | 167.24B | 161.65B |
TAK Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-03-31 | 2 | 147.05B | 163.43B | 156.41B | 260.22B | 282.2B | 272.78B |
| 2027-12-31 | 3 | 195.03B | 216.77B | 207.44B | 272.8B | 295.85B | 285.96B |
| 2027-09-30 | 2 | 241.47B | 268.38B | 256.84B | 273.04B | 296.1B | 286.21B |
| 2027-06-30 | 2 | 100.92B | 112.17B | 107.34B | 267.02B | 289.57B | 279.9B |
| 2027-03-31 | 3 | -38.22B | -34.39B | -36.57B | 266.33B | 288.83B | 279.18B |
| 2026-12-31 | 3 | 79.86B | 88.76B | 84.94B | 280.15B | 303.81B | 293.66B |
TAK Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2028-03-31 | 2 | 1.06T | 1.15T | 1.11T | 1 | 47.05609 | 52.29946 | 50.05044 |
| 2027-12-31 | 3 | 1.11T | 1.21T | 1.17T | 1 | 62.41115 | 69.36551 | 66.3826 |
| 2027-09-30 | 2 | 1.11T | 1.21T | 1.17T | 1 | 77.27092 | 85.88107 | 82.18795 |
| 2027-06-30 | 2 | 1.09T | 1.18T | 1.14T | 1 | 32.2953 | 35.89391 | 34.35037 |
| 2027-03-31 | 3 | 1.09T | 1.18T | 1.14T | 1 | -12.22957 | -11.00347 | -11.70366 |
| 2026-12-31 | 3 | 1.14T | 1.24T | 1.2T | 1 | 25.55433 | 28.4018 | 27.18044 |